Verition Fund Management’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.04M | Buy |
+40,000
| New | +$4.14M | 0.02% | 750 |
|
|
2026
Q1 | – | Sell |
-23,700
| Closed | -$2.52M | – | 2649 |
|
|
2025
Q4 | $2.52M | Sell |
23,700
-12,470
| -34% | -$1.45M | 0.01% | 1404 |
|
|
2025
Q3 | $4.59M | Sell |
36,170
-77,051
| -68% | -$9.17M | 0.02% | 1236 |
|
|
2025
Q2 | $13.9M | Buy |
113,221
+45,107
| +66% | +$5.15M | 0.06% | 364 |
|
|
2025
Q1 | $6.9M | Buy |
68,114
+18,554
| +37% | +$1.81M | 0.03% | 642 |
|
|
2024
Q4 | $4.58M | Buy |
49,560
+43,965
| +786% | +$4.32M | 0.02% | 945 |
|
|
2024
Q3 | $541K | Buy |
5,595
+40
| +0.7% | +$3.6K | ﹤0.01% | 2275 |
|
|
2024
Q2 | $477K | Sell |
5,555
-1,475
| -21% | -$124K | ﹤0.01% | 2076 |
|
|
2024
Q1 | $581K | Buy |
7,030
+1,080
| +18% | +$79.1K | ﹤0.01% | 1934 |
|
|
2023
Q4 | $397K | Sell |
5,950
-305
| -5% | -$19.8K | ﹤0.01% | 1635 |
|
|
2023
Q3 | $420K | Buy |
6,255
+500
| +9% | +$34.4K | ﹤0.01% | 1535 |
|
|
2023
Q2 | $390K | Buy |
5,755
+200
| +4% | +$12.5K | 0.01% | 1379 |
|
|
2023
Q1 | $301K | Buy |
+5,555
| New | +$323K | ﹤0.01% | 1523 |
|
|
2022
Q3 | – | Sell |
-32,679
| Closed | -$1.46M | – | 3087 |
|
|
2022
Q2 | $1.46M | Buy |
+32,679
| New | +$1.68M | 0.03% | 835 |
|
|
2022
Q1 | – | Sell |
-7,220
| Closed | -$375K | – | 2801 |
|
|
2021
Q4 | $375K | Sell |
7,220
-50,167
| -87% | -$2.59M | ﹤0.01% | 1872 |
|
|
2021
Q3 | $3.43M | Buy |
57,387
+46,622
| +433% | +$2.93M | 0.03% | 385 |
|
|
2021
Q2 | $668K | Buy |
10,765
+7,341
| +214% | +$489K | 0.01% | 970 |
|
|
2021
Q1 | $223K | Buy |
+3,424
| New | +$223K | ﹤0.01% | 1274 |
|
|
2020
Q3 | – | Sell |
-9,793
| Closed | -$482K | – | 1138 |
|
|
2020
Q2 | $482K | Buy |
+9,793
| New | +$528K | 0.02% | 627 |
|
|
2020
Q1 | – | Sell |
-11,366
| Closed | -$626K | – | 726 |
|
|
2019
Q4 | $626K | Buy |
+11,366
| New | +$617K | 0.01% | 592 |
|
|
2019
Q3 | – | Sell |
-4,515
| Closed | -$228K | – | 1117 |
|
|
2019
Q2 | $228K | Buy |
+4,515
| New | +$219K | 0.01% | 938 |
|
|
2018
Q4 | – | Sell |
-22,295
| Closed | -$1.38M | – | 927 |
|
|
2018
Q3 | $1.38M | Buy |
22,295
+2,517
| +13% | +$153K | 0.05% | 441 |
|
|
2018
Q2 | $1.07M | Buy |
+19,778
| New | +$988K | 0.07% | 380 |
|
|
2018
Q1 | – | Sell |
-6,535
| Closed | -$257K | – | 1168 |
|
|
2017
Q4 | $257K | Buy |
6,535
+25
| +0.4% | +$951 | 0.02% | 727 |
|
|
2017
Q3 | $240K | Buy |
+6,510
| New | +$232K | 0.02% | 986 |
|
|
2017
Q1 | – | Sell |
-19,431
| Closed | -$637K | – | 1235 |
|
|
2016
Q4 | $637K | Sell |
19,431
-661
| -3% | -$21.4K | 0.05% | 433 |
|
|
2016
Q3 | $648K | Buy |
+20,092
| New | +$651K | 0.07% | 372 |
|
|
2014
Q1 | – | Sell |
-7,846
| Closed | -$208K | – | 527 |
|
|
2013
Q4 | $208K | Buy |
+7,846
| New | +$218K | 0.04% | 387 |
|
Other funds holding EHC
Verition Fund Management's EHC Position: Q2 2026 in Review
Verition Fund Management opened a new position in Encompass Health (EHC) in Q2 2026: 40,000 shares worth $4.04M. The stake represents 0.02% of the portfolio and ranks #750 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in EHC as recently as Q4 2025.
Verition Fund Management first reported a position in EHC in Q4 2013 and has held it in 28 quarters since. The position peaked at $13.9M in Q2 2025. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.
- Verition Fund Management held 40,000 shares of Encompass Health worth $4.04M as of Q2 2026.
- Encompass Health was a new Verition Fund Management position in Q2 2026.
- Encompass Health made up 0.02% of Verition Fund Management's portfolio in Q2 2026, its #750 holding.
- Verition Fund Management first reported a position in Encompass Health in Q4 2013 and has held it in 28 quarters since.
- Verition Fund Management's Encompass Health position peaked at $13.9M in Q2 2025.
- 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.
Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.